These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 27080526)

  • 41. Impact of continuous-flow left ventricular assist device support on right ventricular function.
    Morgan JA; Paone G; Nemeh HW; Murthy R; Williams CT; Lanfear DE; Tita C; Brewer RJ
    J Heart Lung Transplant; 2013 Apr; 32(4):398-403. PubMed ID: 23402946
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Present-Day Hospital Readmissions after Left Ventricular Assist Device Implantation: A Large Single-Center Study.
    Hernandez RE; Singh SK; Hoang DT; Ali SW; Elayda MA; Mallidi HR; Frazier OH; Meyers DE
    Tex Heart Inst J; 2015 Oct; 42(5):419-29. PubMed ID: 26504434
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ventricular reconditioning and pump explantation in patients supported by continuous-flow left ventricular assist devices.
    Frazier OH; Baldwin AC; Demirozu ZT; Segura AM; Hernandez R; Taegtmeyer H; Mallidi H; Cohn WE
    J Heart Lung Transplant; 2015 Jun; 34(6):766-72. PubMed ID: 25447571
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Left ventricular assist device implantation with and without concomitant tricuspid valve surgery: a systematic review and meta-analysis.
    Veen KM; Muslem R; Soliman OI; Caliskan K; Kolff MEA; Dousma D; Manintveld OC; Birim O; Bogers AJJC; Takkenberg JJM
    Eur J Cardiothorac Surg; 2018 Oct; 54(4):644-651. PubMed ID: 29897441
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Surgical approach to continuous-flow left ventricular assist device explantation: A comparison of outcomes.
    Baldwin AC; Sandoval E; Letsou GV; Mallidi HR; Cohn WE; Frazier OH
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):192-8. PubMed ID: 26344685
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Concomitant tricuspid valve surgery during implantation of continuous-flow left ventricular assist devices: a Society of Thoracic Surgeons database analysis.
    Robertson JO; Grau-Sepulveda MV; Okada S; O'Brien SM; Matthew Brennan J; Shah AS; Itoh A; Damiano RJ; Prasad S; Silvestry SC
    J Heart Lung Transplant; 2014 Jun; 33(6):609-17. PubMed ID: 24661682
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased cyclic guanosine monophosphate levels and continuous-flow left-ventricular assist devices: Implications for gastrointestinal bleeding.
    Grosman-Rimon L; Tumiati LC; Fuks A; Jacobs I; Lalonde SD; Cherney DZ; Rao V
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):219-27. PubMed ID: 26515873
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Echocardiographic predictors of adverse outcomes after continuous left ventricular assist device implantation.
    Topilsky Y; Oh JK; Shah DK; Boilson BA; Schirger JA; Kushwaha SS; Pereira NL; Park SJ
    JACC Cardiovasc Imaging; 2011 Mar; 4(3):211-22. PubMed ID: 21414567
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Limited Utility of Tricuspid Valve Repair at the Time of Left Ventricular Assist Device Implantation.
    Song HK; Gelow JM; Mudd J; Chien C; Tibayan FA; Hollifield K; Naftel D; Kirklin J
    Ann Thorac Surg; 2016 Jun; 101(6):2168-74. PubMed ID: 27139368
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intraplatelet reactive oxygen species, mitochondrial damage and platelet apoptosis augment non-surgical bleeding in heart failure patients supported by continuous-flow left ventricular assist device.
    Mondal NK; Sorensen EN; Hiivala NJ; Feller ED; Pham SM; Griffith BP; Wu ZJ
    Platelets; 2015; 26(6):536-44. PubMed ID: 25167344
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of aortic valve commissural fusion after support with continuous-flow left ventricular assist device.
    Martina JR; Schipper ME; de Jonge N; Ramjankhan F; de Weger RA; Lahpor JR; Vink A
    Interact Cardiovasc Thorac Surg; 2013 Oct; 17(4):616-24. PubMed ID: 23798641
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.
    Kamdar F; John R; Eckman P; Colvin-Adams M; Shumway SJ; Liao K
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):575-81. PubMed ID: 23321132
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Implantation of the continuous flow HeartWare® left ventricular assist device.
    Carrel T; Englberger L; Kadner A; Mohacsi P
    Multimed Man Cardiothorac Surg; 2013; 2013():mmt010. PubMed ID: 24413008
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Current state of ventricular assist devices.
    Caccamo M; Eckman P; John R
    Curr Heart Fail Rep; 2011 Jun; 8(2):91-8. PubMed ID: 21336538
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heart transplantation and left ventricular assist device therapy: two comparable options in end-stage heart failure?
    Garbade J; Barten MJ; Bittner HB; Mohr FW
    Clin Cardiol; 2013 Jul; 36(7):378-82. PubMed ID: 23595910
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Changes in Aortic Wall Structure, Composition, and Stiffness With Continuous-Flow Left Ventricular Assist Devices: A Pilot Study.
    Ambardekar AV; Hunter KS; Babu AN; Tuder RM; Dodson RB; Lindenfeld J
    Circ Heart Fail; 2015 Sep; 8(5):944-52. PubMed ID: 26136459
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Which advanced heart failure therapy strategy is optimal for patients over 60 years old?
    Gernhofer YK; Braun OO; Brambatti M; Bui QM; Silva Enciso J; Greenberg BH; Adler E; Pretorius V
    J Cardiovasc Surg (Torino); 2019 Apr; 60(2):251-258. PubMed ID: 30168306
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term continuous flow left ventricular assist device support and end-organ function: prospects for destination therapy.
    Slaughter MS
    J Card Surg; 2010 Jul; 25(4):490-4. PubMed ID: 20642766
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Concomitant tricuspid valve repair or replacement during left ventricular assist device implant demonstrates comparable outcomes in the long term.
    Deo SV; Hasin T; Altarabsheh SE; McKellar SH; Shah IK; Durham L; Stulak JM; Daly RC; Park SJ; Joyce LD
    J Card Surg; 2012 Nov; 27(6):760-6. PubMed ID: 23173864
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Extracorporeal Life Support Bridge to Ventricular Assist Device: The Double Bridge Strategy.
    Marasco SF; Lo C; Murphy D; Summerhayes R; Quayle M; Zimmet A; Bailey M
    Artif Organs; 2016 Jan; 40(1):100-6. PubMed ID: 25980985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.